Regulus Therapeutics INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Regulus Therapeutics files an amendment to its annual report on Form 10-K to include information required in Part III, which was not initially included due to the delay in filing the definitive proxy statement.
Regulus Therapeutics advances farabursen clinical development for ADPKD while navigating financial uncertainties.
Regulus Therapeutics Inc. has filed its annual 10-K report, disclosing executive salary increases and providing an overview of its financial status and clinical development programs.